Arvinas, Inc. (ARVN)

12.18 0.00 (0.00%) USD  |  NASDAQ  |  Dec 24, 12:59
12.19 +0.01 (+0.08%) After-Hours: 13:59
More

Arvinas SG&A Expense (TTM): 107.00M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for ARVN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Pfizer Inc. 13.91B
Assembly Biosciences, Inc. 18.80M
Alnylam Pharmaceuticals, Inc. 1.181B
Verastem, Inc. 67.48M
Sarepta Therapeutics, Inc. 527.29M